Olivier Goldstein

• Advised Bridgepoint on the €890m acquisition of Laboratoires Vivacy
• Advised LBO France on its €230m sale of Dutscher Group to Vivo Capital
• Won two recent major tax disputes for Laboratoires Menarini
• Advised several high net worth individuals on their impatriation in France or their expatriation from France

Olivier advises on tax issues related to domestic and cross-border transactions involving mergers, acquisitions and group restructuring operations with a specific focus on the pharmaceutical industry and, more generally, the healthcare, new technologies and finance sectors.

He also advises company directors and key managers, as well as high net worth individuals, in the tax structuring of their professional and personal assets. His expertise also includes tax litigation and criminal proceedings relating to tax offences.